Peter L. Nara

Fundador en Biological Mimetics, Inc. .

Health Technology

Perfil

Peter L.
Nara was the founder of Lantern Pharma, Inc. (founded in 2013) where he held the title of Director & Chief Business Officer.
He was also the founder of Biological Mimetics, Inc. (founded in 1996) where he held the title of Chairman, President & Chief Executive Officer.
Currently, Dr. Nara is the CSO, Director & VP-Business Development at Keystone Bio, Inc.

Cargos activos de Peter L. Nara

Empresas	Cargo	Inicio
Biological Mimetics, Inc. Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD.	Fundador	01/01/1996
Keystone Bio, Inc. Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO.	Director Técnico/Científico/I+D	-

Todos los cargos activos de Peter L. Nara

Antiguos cargos conocidos de Peter L. Nara.

Empresas	Cargo	Fin
LANTERN PHARMA INC.	Fundador	-

Ver el detalle de la experiencia de Peter L. Nara.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Peter L. Nara.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
LANTERN PHARMA INC.	Health Technology

Empresas privadas	2
Biological Mimetics, Inc. Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD.	Health Technology
Keystone Bio, Inc. Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO.	Health Technology

Ver las conexiones de la empresa